• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全血免疫表型分析揭示幼稚中性粒细胞与 VD2 T 细胞比值是重症 COVID-19 的早期标志物。

Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19.

机构信息

Infectious Disease Horizontal Technology Center, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.

Singapore Immunology Network, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.

出版信息

Nat Commun. 2020 Oct 16;11(1):5243. doi: 10.1038/s41467-020-19080-6.

DOI:10.1038/s41467-020-19080-6
PMID:33067472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7568554/
Abstract

SARS-CoV-2 is the novel coronavirus responsible for the current COVID-19 pandemic. Severe complications are observed only in a small proportion of infected patients but the cellular mechanisms underlying this progression are still unknown. Comprehensive flow cytometry of whole blood samples from 54 COVID-19 patients reveals a dramatic increase in the number of immature neutrophils. This increase strongly correlates with disease severity and is associated with elevated IL-6 and IP-10 levels, two key players in the cytokine storm. The most pronounced decrease in cell counts is observed for CD8 T-cells and VD2 γδ T-cells, which both exhibit increased differentiation and activation. ROC analysis reveals that the count ratio of immature neutrophils to VD2 (or CD8) T-cells predicts pneumonia onset (0.9071) as well as hypoxia onset (0.8908) with high sensitivity and specificity. It would thus be a useful prognostic marker for preventive patient management and improved healthcare resource management.

摘要

SARS-CoV-2 是导致当前 COVID-19 大流行的新型冠状病毒。只有一小部分感染患者会出现严重并发症,但导致这种进展的细胞机制仍不清楚。对 54 名 COVID-19 患者的全血样本进行全面流式细胞术分析显示,不成熟中性粒细胞的数量急剧增加。这种增加与疾病的严重程度密切相关,并与升高的 IL-6 和 IP-10 水平相关,这两种水平都是细胞因子风暴的关键因素。CD8 T 细胞和 VD2 γδ T 细胞的细胞计数下降最为明显,这两种细胞都表现出分化和激活的增加。ROC 分析表明,不成熟中性粒细胞与 VD2(或 CD8)T 细胞的计数比值可预测肺炎发作(0.9071)和缺氧发作(0.8908),具有高灵敏度和特异性。因此,它将是一种有用的预后标志物,用于预防性的患者管理和改善医疗资源管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8c1/7568554/974366a92de6/41467_2020_19080_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8c1/7568554/17947017794b/41467_2020_19080_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8c1/7568554/e9791e5fb238/41467_2020_19080_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8c1/7568554/6622456d9afd/41467_2020_19080_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8c1/7568554/0b7f7fd33166/41467_2020_19080_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8c1/7568554/974366a92de6/41467_2020_19080_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8c1/7568554/17947017794b/41467_2020_19080_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8c1/7568554/e9791e5fb238/41467_2020_19080_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8c1/7568554/6622456d9afd/41467_2020_19080_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8c1/7568554/0b7f7fd33166/41467_2020_19080_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8c1/7568554/974366a92de6/41467_2020_19080_Fig5_HTML.jpg

相似文献

1
Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19.全血免疫表型分析揭示幼稚中性粒细胞与 VD2 T 细胞比值是重症 COVID-19 的早期标志物。
Nat Commun. 2020 Oct 16;11(1):5243. doi: 10.1038/s41467-020-19080-6.
2
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.SARS-CoV-2 感染患者外周血淋巴细胞反应和细胞因子谱的纵向特征。
EBioMedicine. 2020 May;55:102763. doi: 10.1016/j.ebiom.2020.102763. Epub 2020 Apr 18.
3
Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.71 例 COVID-19 患者的临床特征和免疫损伤机制。
mSphere. 2020 Jul 15;5(4):e00362-20. doi: 10.1128/mSphere.00362-20.
4
Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.严重 COVID-19 诱导的急性呼吸窘迫综合征中的促炎和抗炎反应:一项观察性初步研究。
Front Immunol. 2020 Oct 6;11:581338. doi: 10.3389/fimmu.2020.581338. eCollection 2020.
5
Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.利用 IL-2R/淋巴细胞预测 COVID-19 患者的临床进展。
Clin Exp Immunol. 2020 Jul;201(1):76-84. doi: 10.1111/cei.13450. Epub 2020 May 15.
6
Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2.免疫特征可区分与 SARS-CoV-2 相关的重症疾病患者。
Immunol Res. 2020 Dec;68(6):398-404. doi: 10.1007/s12026-020-09156-2. Epub 2020 Sep 28.
7
Neutrophil-to-Lymphocyte Ratios Are Closely Associated With the Severity and Course of Non-mild COVID-19.中性粒细胞与淋巴细胞比值与非轻症 COVID-19 的严重程度和病程密切相关。
Front Immunol. 2020 Sep 2;11:2160. doi: 10.3389/fimmu.2020.02160. eCollection 2020.
8
Immune dysfunction following COVID-19, especially in severe patients.新冠病毒感染后免疫功能障碍,尤其是在重症患者中。
Sci Rep. 2020 Sep 28;10(1):15838. doi: 10.1038/s41598-020-72718-9.
9
Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.SARS-CoV-2 对 CD8 细胞的选择性减少与 COVID-19 患者的预后不良和全身炎症有关。
Clin Immunol. 2020 Aug;217:108486. doi: 10.1016/j.clim.2020.108486. Epub 2020 May 29.
10
Immune Parameters and COVID-19 Infection - Associations With Clinical Severity and Disease Prognosis.免疫参数与 COVID-19 感染——与临床严重程度和疾病预后的关联。
Front Cell Infect Microbiol. 2020 Jun 30;10:364. doi: 10.3389/fcimb.2020.00364. eCollection 2020.

引用本文的文献

1
Evolution of Blood Innate Immune Cell Phenotypes Following SARS-CoV-2 Infection in Hospitalized Patients with COVID-19.新冠病毒肺炎住院患者感染新型冠状病毒2后血液固有免疫细胞表型的演变
Cells. 2025 Jul 17;14(14):1093. doi: 10.3390/cells14141093.
2
Type 1 innate lymphoid cell-immature neutrophil axis suppresses acute tissue inflammation.1型天然淋巴细胞-未成熟中性粒细胞轴抑制急性组织炎症。
Nat Commun. 2025 Jul 17;16(1):6574. doi: 10.1038/s41467-025-61504-8.
3
Neutrophil heterogeneity in Kawasaki disease and multisystem inflammatory syndrome in children.

本文引用的文献

1
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.致病性T细胞和炎性单核细胞在重症COVID-19患者中引发炎症风暴。
Natl Sci Rev. 2020 Jun;7(6):998-1002. doi: 10.1093/nsr/nwaa041. Epub 2020 Mar 13.
2
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity.严重急性呼吸综合征冠状病毒 2 型(COVID-19)病毒动力学和免疫相关性分析。
Clin Infect Dis. 2021 Nov 2;73(9):e2932-e2942. doi: 10.1093/cid/ciaa1280.
3
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.
川崎病和儿童多系统炎症综合征中的中性粒细胞异质性
Pediatr Res. 2025 Jun 19. doi: 10.1038/s41390-025-04200-z.
4
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection.可溶性CD13是新型冠状病毒感染中中性粒细胞诱导的血栓形成性炎症的潜在介质。
JCI Insight. 2025 Apr 1;10(9). doi: 10.1172/jci.insight.184975. eCollection 2025 May 8.
5
Monitoring Macrophage Polarization in Infectious Disease, Lesson From SARS-CoV-2 Infection.监测传染病中的巨噬细胞极化:来自新冠病毒感染的经验教训
Rev Med Virol. 2025 May;35(3):e70034. doi: 10.1002/ird3.70006.
6
Neutrophils Display Novel Partners of Cytosolic Proliferating Cell Nuclear Antigen Involved in Interferon Response in COVID-19 Patients.中性粒细胞显示出参与COVID-19患者干扰素反应的胞质增殖细胞核抗原新伴侣。
J Innate Immun. 2025;17(1):154-175. doi: 10.1159/000543633. Epub 2025 Feb 27.
7
CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection.CXCL12可改善新型冠状病毒2型感染中的中性粒细胞增多及疾病严重程度。
J Clin Invest. 2025 Jan 7;135(4):e188222. doi: 10.1172/JCI188222.
8
The FLARE Score and Circulating Neutrophils in Patients with Cancer and COVID-19 Disease.癌症合并新型冠状病毒肺炎患者的FLARE评分与循环中性粒细胞
Cancers (Basel). 2024 Aug 26;16(17):2974. doi: 10.3390/cancers16172974.
9
Emergence of dysfunctional neutrophils with a defect in arginase-1 release in severe COVID-19.严重 COVID-19 患者中出现 Arg1 酶释放缺陷的功能失调中性粒细胞。
JCI Insight. 2024 Sep 10;9(17):e171659. doi: 10.1172/jci.insight.171659.
10
Longitudinal dynamic single-cell mass cytometry analysis of peripheral blood mononuclear cells in COVID-19 patients within 6 months after viral RNA clearance.COVID-19 患者病毒 RNA 清除后 6 个月内外周血单个核细胞的纵向动态单细胞质谱流式细胞分析。
BMC Infect Dis. 2024 Jun 6;24(1):567. doi: 10.1186/s12879-024-09464-0.
血清钙卫蛋白和异常髓系细胞亚群可区分 COVID-19 重症与轻症。
Cell. 2020 Sep 17;182(6):1401-1418.e18. doi: 10.1016/j.cell.2020.08.002. Epub 2020 Aug 5.
4
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.严重的 COVID-19 以髓系细胞失调为特征。
Cell. 2020 Sep 17;182(6):1419-1440.e23. doi: 10.1016/j.cell.2020.08.001. Epub 2020 Aug 5.
5
Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes.COVID-19 流行病学:临床特征、危险因素和结局的系统评价和荟萃分析。
J Med Virol. 2021 Mar;93(3):1449-1458. doi: 10.1002/jmv.26424. Epub 2020 Aug 25.
6
COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.COVID-19 严重程度与 CD1c+ DCs 和炎症性过渡和非经典单核细胞在肺部的重新分布相关。
J Clin Invest. 2020 Dec 1;130(12):6290-6300. doi: 10.1172/JCI140335.
7
Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population.SARS-CoV-2 大流行中的种族和民族差异:对美国多元化大都市人口 COVID-19 观察性登记的分析。
BMJ Open. 2020 Aug 11;10(8):e039849. doi: 10.1136/bmjopen-2020-039849.
8
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.严重 COVID-19 患者的 I 型干扰素活性和炎症反应受损。
Science. 2020 Aug 7;369(6504):718-724. doi: 10.1126/science.abc6027. Epub 2020 Jul 13.
9
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.COVID-19 肺炎患者中标记的 T 细胞激活、衰老、衰竭和向 TH17 的倾斜。
Nat Commun. 2020 Jul 6;11(1):3434. doi: 10.1038/s41467-020-17292-4.
10
The Aging of γδ T Cells.γδ T 细胞的衰老。
Cells. 2020 May 9;9(5):1181. doi: 10.3390/cells9051181.